Overview

Study Evaluating Rapamune in Patients After Kidney Transplantation

Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain data on the effectiveness and safety of Rapamune under everyday conditions
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Everolimus
Sirolimus